SCHEMBL30689372

SCHEMBL30689372

N#Cc1ccc(Oc2cncc(F)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.57
SCN9A Q15858 1/20 0.46
GRM5 P41594 1/20 0.43
PARP15 Q460N3 1/20 0.42
PARP10 Q53GL7 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
PRMT5 O14744 1/20 0.42
WDR77 Q9BQA1 1/20 0.42
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
IL18 Q14116 1/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27368527 1.00 CYP19A1 (0.57) CYP19A1SCN9AGRM5PARP15PARP10
SCHEMBL2425876 0.83 CYP3A4 (0.50) CYP19A1SCN9AGRM5KDM4EMEN1
SCHEMBL8546374 0.80 FFAR1 (0.51) CYP19A1PARP15PARP10PARP2KDM4E
SCHEMBL30689378 0.80 CYP19A1 (0.57) CYP19A1SCN9AGRM5PARP15PARP10
SCHEMBL27368501 0.80 CYP19A1 (0.57) CYP19A1SCN9AGRM5PARP15PARP10
SCHEMBL27368481 0.80 CYP19A1 (0.53) CYP19A1SCN9AGRM5PARP15PARP10
SCHEMBL30689363 0.80 CYP19A1 (0.53) CYP19A1SCN9AGRM5PARP15PARP10
SCHEMBL3138833 0.78 PARP15 (0.53) CYP19A1PARP15PARP10PARP2KDM4E
SCHEMBL17456350 0.77 CYP3A4 (0.38) CYP3A4
SCHEMBL30689417 0.77 AR (0.48) CYP19A1KDM4EMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 CN disclosed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 WO disclosed